Microsphere-based Biodegradable Implant

Description: A combination of microspheres and biodegradable polymer scaffolding to form a biodegradable implant.

Product Details

User: Female

Hormonal: Yes

Delivery Method: Subdermal

Duration Type: Long-acting

Duration: 18 months

  • Single administration every 18 months

Active Pharmaceutical Ingredient (API):
  • levonorgestrel

Multipurpose Preventive Technology (MPT): Yes

Status Details

Developer: FHI 360, University of Washington

Project Phase: Pre-Clinical and Clinical Development

Development Stage: Pre-clinical

Began discovery in: 2015

Active Development: No

Additional Information


Vertical Tabs